魯信創投(600783.SH)與控股股東共同對魯信金控同比例增資
格隆匯1月10日丨魯信創投(600783.SH)公佈,山東省魯信金融控股有限公司(“魯信金控”)現有股東山東省魯信投資控股集團有限公司(“魯信集團”)及公司分別以現金形式同比例認繳魯信金控新增註冊資本15000萬元、2566.8107萬元,實際增資價款分別為16650萬元、2849.16萬元。
魯信集團為公司控股股東,截至目前,魯信集團持有公司約5.1786億股,持股比例69.57%。同時,魯信集團對魯信金控持股比例85.39%。公司及控股股東魯信集團對魯信金控同比例增資構成了上市公司的關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.